Home > Riviste > Minerva Gastroenterologica e Dietologica > Fascicoli precedenti > Minerva Gastroenterologica e Dietologica 2019 September;65(3) > Minerva Gastroenterologica e Dietologica 2019 September;65(3):187-92

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

ORIGINAL ARTICLE   

Minerva Gastroenterologica e Dietologica 2019 September;65(3):187-92

DOI: 10.23736/S1121-421X.19.02593-5

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

Blue light emitting diodes cripple Helicobacter pylori by targeting its virulence factors

Homa DARMANI , Ehda AM SMADI, Sereen MB BATAINEH

Department of Applied Biological Sciences, Faculty of Science, Jordan University of Science and Technology, Irbid, Jordan



BACKGROUND: The endogenous photosensitizing porphyrins in Helicobacter pylori (H. pylori), make blue light therapy an attractive addition to the armamentarium in the war against this very prevalent and difficult to treat infectious agent.
METHODS: In the current study we examined in vitro the effect of blue LED (Light Emitting Diode) irradiation for 1-6 minutes on the viability and virulence factors of H. pylori, which allow this microorganism to colonize and establish infection. Specifically, we examined the effects of blue LED on urease production, motility, adhesion and biofilm formation.
RESULTS: We found that exposure to blue LED for 1-6 minutes significantly decreased the viability of H. pylori and caused decreased urease activity, as well as, swarming motility. Furthermore, blue LED irradiation for 6 minutes caused greater than 50% disruption of preformed mature biofilms of H. pylori, relative to controls.
CONCLUSIONS: Collectively, the results of our in-vitro study indicate that therapy with blue LED may be an added weapon in the eradication of H. pylori by targeting the virulence factors of this very common pathogen. We envisage that phototherapy will have an adjuvant effect on conventional anti-H. pylori therapy, especially considering its efficacy in biofilm disruption and the fact that microorganisms are unlikely to develop resistance as a result of the multi-target effects.


KEY WORDS: Helicobacter pylori; Biofilms; Urease

inizio pagina